HIGHLIGHTS
- What: This study was conducted following the guidelines of the Declaration of Helsinki and the procedures were approved by the Institutional Review Board of the University of Navarra (approval code 010830). For this analysis, the authors used the following exclusion criteria: 234 participants who answered the baseline questionnaire after August 1st, 2019 were excluded to ensure a minimum 2-year follow up period; 2,022 participants were excluded due to lack of follow-up information; the authors further excluded 569 participants who reported a previous cancer diagnosis at the time of recruitment. The study has several limitations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.